ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published online before print January 10, 2007, 10.1183/09031936.00117506
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (4)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Leyten, E. M. S.
Right arrow Articles by Arend, S. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Leyten, E. M. S.
Right arrow Articles by Arend, S. M.
Eur Respir J 2007; 29:1212-1216
Copyright ©ERS Journals Ltd 2007

Effect of tuberculin skin testing on a Mycobacterium tuberculosis-specific interferon-{gamma} assay

E. M. S. Leyten1, C. Prins1, A. W. J. Bossink2, S. Thijsen3, T. H. M. Ottenhoff4, J. T. van Dissel1 and S. M. Arend1

1 Depts of Infectious Diseases and 4 Immunohematology and Blood Transfusion, Leiden University Medical Center, Leiden, 2 Depts of Pulmonology and 3 Microbiology and Immunology, Diakonessenhuis Utrecht/Zeist, Utrecht, The Netherlands.

CORRESPONDENCE: S. M. Arend, Dept of Infectious Diseases, C5P, Leiden University Medical Center, P.O. Box 9600, 2300 RC Leiden, The Netherlands. Fax: 31 715266758. E-mail: S.M.Arend{at}LUMC.nl

Keywords: Diagnosis, immunoassays, interferon, Mycobacterium tuberculosis, skin test, tuberculosis

Received: September 6, 2006
Accepted December 20, 2006

Recently, interferon-{gamma} release assays (IGRA) for specific diagnosis of Mycobacterium tuberculosis infection have become available. In recent UK tuberculosis (TB) guidelines, it has been advised to screen for latent M. tuberculosis infection using the tuberculin skin test (TST), followed by IGRA if the TST is positive. Since TST can boost immune responses to tuberculin, the present authors evaluated whether TST administration affects the result of QuantiFERON®-TB Gold in-tube (QFT-GIT), a whole blood-based IGRA.

QFT-GIT was performed on the day of TST administration and the day of reading in 15 TST-negative subjects, 46 TST-positive subjects with recent or remote exposure to M. tuberculosis and five cured TB patients.

No systematic boosting of QFT-GIT responses from negative to positive was observed. Only in a few TST-positive persons did TST enhance pre-existing QFT-GIT responses.

Screening for latent Mycobacterium tuberculosis infection using tuberculin skin testing followed by interferon-{gamma} release assays on the day of reading is a reliable approach, as the specificity of QuantiFERON®-TB Gold in-tube is not affected by prior tuberculin skin test administration.




This article has been cited by other articles:


Home page
Eur Respir JHome page
L. Richeldi, B. M. Bergamini, and F. Vaienti
Prior tuberculin skin testing does not boost QuantiFERON-TB results in paediatric contacts
Eur. Respir. J., August 1, 2008; 32(2): 524 - 525.
[Full Text] [PDF]


Home page
ChestHome page
J. C. Choi, J. W. Shin, J. Y. Kim, I. W. Park, B. W. Choi, and M.-K. Lee
The Effect of Previous Tuberculin Skin Test on the Follow-up Examination of Whole-Blood Interferon-{gamma} Assay in the Screening for Latent Tuberculosis Infection
Chest, June 1, 2008; 133(6): 1415 - 1420.
[Abstract] [Full Text] [PDF]


Home page
CVIHome page
S. Perry, L. Sanchez, S. Yang, Z. Agarwal, P. Hurst, and J. Parsonnet
Reproducibility of QuantiFERON-TB Gold In-Tube Assay
Clin. Vaccine Immunol., March 1, 2008; 15(3): 425 - 432.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by the European Respiratory Society.